The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Systemic inflammatory response syndrome (SIRS): Where did it come from and is it still relevant today?
Open accessAbstract
The concept of a systemic inflammatory response syndrome (SIRS) to describe the complex pathophysiologic response to an insult such as infection, trauma, burns, pancreatitis, or a variety of other injuries came from a 1991 consensus conference charged with the task of developing an easy-to-apply set of clinical parameters to aid in the early identification of potential candidates to enter into clinical trials to evaluate new treatments for sepsis. There was recognition that a diverse group of injuries produced a common inflammatory response in the host and provided attractive targets for new anti-inflammatory molecules designed to prevent further propagation and/or provide specific treatment. Effective application of these new anti-inflammatory strategies necessitated identification of early clinical markers that could be assessed in real-time and were likely to define a population of patients that would have a beneficial response to the targeted intervention. It was felt that early clinical manifestations might be more readily available to clinicians than more sophisticated and specific assays for inflammatory substances that were systemically released by the network of injurious inflammatory events. Therefore, the early definition of a systemic inflammatory response syndrome (SIRS) was built upon a foundation of basic clinical and laboratory abnormalities that were readily available in almost all clinical settings. With further refinement, it was hoped, that this definition would have a high degree of sensitivity, coupled with a reasonable degree of specificity. This manuscript reviews the derivation, application, utilization, potential benefits, and speculation regarding the future of the SIRS definition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Self-citationEarly goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa040232 · Cited by 2,872
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440
Self-citationBone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309
Dombrovskiy, V. Y., Martin, A. A., Sunderram, J., & Paz, H. L. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000261890.41311.e9 · Cited by 1,249
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
Sepsis: A New Hypothesis for Pathogenesis of the Disease Process
Bone, R. C., Grodzin, C. J., & Balk, R. A. (1997) · Chest · doi:10.1378/chest.112.1.235 · Cited by 1,021
Self-citationSepsis definitions: time for change
Vincent, J.-L., Opal, S. M., Marshall, J. C., & Tracey, K. J. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61815-7 · Cited by 734
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
Self-citationHospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007
Lagu, T., Rothberg, M. B., Shieh, M.-S., Pekow, P. S., Steingrub, J. S., & Lindenauer, P. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232db65 · Cited by 679
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Sepsis syndrome: A valid clinical entity
BONE, R. C., FISHER, C. J., CLEMMER, T. P., SLOTMAN, G. J., METZ, C. A., & BALK, R. A. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00002 · Cited by 537
Self-citationProinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock
Dinarello, C. A. (1997) · Chest · doi:10.1378/chest.112.6_supplement.321s · Cited by 508
Dear SIRS, I'm sorry to say that I don't like you
Vincent, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00029 · Cited by 444
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 442
Before–after study of a standardized hospital order set for the management of septic shock*
Micek, S. T., Roubinian, N., Heuring, T., Bode, M., Williams, J., Harrison, C., Murphy, T., Prentice, D., Ruoff, B. E., & Kollef, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000241151.25426.d7 · Cited by 372
Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., et al. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00003 · Cited by 361
Marshall, J. C., & Reinhart, K. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a02afc · Cited by 294
Combination Biomarkers to Diagnose Sepsis in the Critically Ill Patient
Gibot, S., Béné, M. C., Noel, R., Massin, F., Guy, J., Cravoisy, A., Barraud, D., De Carvalho Bittencourt, M., Quenot, J.-P., Bollaert, P.-E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0037oc · Cited by 294
SEVERE SEPSIS AND SEPTIC SHOCK
Balk, R. A. (2000) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70106-8 · Cited by 277
Self-citationBone, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540070061032 · Cited by 224
Bone, R. C. (1991) · Chest · doi:10.1378/chest.100.3.802 · Cited by 193
Evaluation of Definitions for Sepsis
Knaus, W. A., Sun, X., Nystrom, P.-O., & Wagner, D. P. (1992) · Chest · doi:10.1378/chest.101.6.1656 · Cited by 187
BALK, R. A. (2000) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70113-5 · Cited by 152
Self-citationEFFICACY AND SAFETY OF DOPAMINE VERSUS NOREPINEPHRINE IN THE MANAGEMENT OF SEPTIC SHOCK
Patel, G. P., Grahe, J. J. S., Sperry, M., Singla, S., Elpern, E. H., Lateef, O., & BALK, R. A. (2010) · Shock · doi:10.1097/shk.0b013e3181c6ba6f · Cited by 141
Self-citationA Critical Evaluation of New Agents for the Treatment of Sepsis
Bone, R. C. (1991) · JAMA · doi:10.1001/jama.1991.03470120088038 · Cited by 109
Marshall, J. C. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0045-1 · Cited by 85
Novel Therapies for Septic Shock Over the Past 4 Decades
Suffredini, A. F., & Munford, R. S. (2011) · JAMA · doi:10.1001/jama.2011.909 · Cited by 78
Septic Shock — Evaluating Another Failed Treatment
Wenzel, R. P., & Edmond, M. B. (2012) · New England Journal of Medicine · doi:10.1056/nejme1203412 · Cited by 78
Rivers, E. P., Jaehne, A. K., Nguyen, H. B., Papamatheakis, D. G., Singer, D., Yang, J. J., Brown, S., & Klausner, H. (2013) · Shock · doi:10.1097/shk.0b013e31827dafa7 · Cited by 69
Recent Developments in the Diagnosis and Management of Severe Sepsis
Wheeler, A. P. (2007) · CHEST Journal · doi:10.1378/chest.06-2535 · Cited by 46
Temporal trends in patient characteristics and survival of intensive care admissions with sepsis
Dreiher, J., Almog, Y., Sprung, C. L., Codish, S., Klein, M., Einav, S., Bar‐Lavie, Y., Singer, P., Nimrod, A., Sachs, J. D., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236f7b8 · Cited by 42
Cited by
Sepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
Prescott, H. C., Calfee, C. S., Thompson, B. T., Angus, D. C., & Liu, V. X. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2544cp · Cited by 322
Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection
Margraf, A., Ludwig, N., Zarbock, A., & Rossaint, J. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005175 · Cited by 285
Zinovkin, R. A., & Zamyatnin, A. A. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666181127151059 · Cited by 209
Metadata
- Authors
- Balk, R. A.
- Venue
- Virulence
- Publisher
- Informa UK Limited
- Published
- 2013-11-13
- Volume
- 5
- Issue
- 1
- Pages
- 20-26
- ISSN
- 2150-5594 (ISSN-L)
- 2150-5608
- OpenAlex
- W1984213393
- Cited by
- 315
- References
- 44
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.